Type 2 diabetes can lead to a variety of complications if blood sugar levels are left unchecked, but the symptoms can be hard ...

This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...

Diabetes Alert Day recognizes diabetes and its complications. One condition, known as diabetic peripheral neuropathy, affects ...

Alnylam Pharmaceuticals ALNY announced that the FDA had approved its regulatory filing seeking the label expansion of its ...

Alnylam (ALNY) announced the FDA approval of the supplemental New Drug Application for its RNAi therapeutic, Amvuttra, for the treatment of the ...

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...

Chronic inflammatory demyelinating polyneuropathy (CIPD) can have a substantial impact on patients everyday life and, ...

If you’re suffering from stabbing pain, numbness, tingling, or a burning sensation in your arms, legs, hands, or feet, you may be experiencing peripheral neuropathy. At Regenerative ...

Hand cooling and compression are highly effective in preventing chemotherapy-induced peripheral neuropathy, according to a ...

U.S.A.I.D. Global Health The United States was the major funder of tuberculosis programs. Now hundreds of thousands of sick patients can’t find tests or drugs, and risk spreading the disease ...

“Today’s approval of WAINZUA in Europe offers adults with hereditary transthyretin-mediated amyloidosis with polyneuropathy a new, self-administered treatment option that provides consistent ...

AstraZeneca and Ionis Pharmaceuticals’ polyneuropathy drug has won approval in the European ... The companies have positioned Wainzua as a differentiated treatment for ATTRv-PN, as it is the first ...